These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27451122)

  • 1. The Dual Role of Senescence in Pancreatic Ductal Adenocarcinoma.
    Porciuncula A; Hajdu C; David G
    Adv Cancer Res; 2016; 131():1-20. PubMed ID: 27451122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arrested development and the great escape--the role of cellular senescence in pancreatic cancer.
    Moir JA; White SA; Mann J
    Int J Biochem Cell Biol; 2014 Dec; 57():142-8. PubMed ID: 25461770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic Cancer and Cellular Senescence: Tumor Microenvironment under the Spotlight.
    Cortesi M; Zanoni M; Pirini F; Tumedei MM; Ravaioli S; Rapposelli IG; Frassineti GL; Bravaccini S
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic cancer: New insights into PDAC growth promotion via a BAG3-mediated paracrine loop.
    Ray K
    Nat Rev Gastroenterol Hepatol; 2015 Dec; 12(12):669. PubMed ID: 26577348
    [No Abstract]   [Full Text] [Related]  

  • 5. Pancreatic cancer development and progression: remodeling the model.
    Real FX; Cibrián-Uhalte E; Martinelli P
    Gastroenterology; 2008 Sep; 135(3):724-8. PubMed ID: 18692502
    [No Abstract]   [Full Text] [Related]  

  • 6. Targeting cathepsins: a new glimmer of hope for pancreatic cancer therapy?
    Michl P
    Gut; 2012 Jun; 61(6):790-1. PubMed ID: 22287597
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of Langerhans islets in pancreatic ductal adenocarcinoma.
    Pour PM
    Front Biosci; 1997 Jun; 2():d271-82. PubMed ID: 9206985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma.
    Oji Y; Nakamori S; Fujikawa M; Nakatsuka S; Yokota A; Tatsumi N; Abeno S; Ikeba A; Takashima S; Tsujie M; Yamamoto H; Sakon M; Nezu R; Kawano K; Nishida S; Ikegame K; Kawakami M; Tsuboi A; Oka Y; Yoshikawa K; Aozasa K; Monden M; Sugiyama H
    Cancer Sci; 2004 Jul; 95(7):583-7. PubMed ID: 15245594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Senescent Human Pancreatic Stellate Cells Secrete CXCR2 Agonist CXCLs to Promote Proliferation and Migration of Human Pancreatic Cancer AsPC-1 and MIAPaCa-2 Cell Lines.
    Takikawa T; Hamada S; Matsumoto R; Tanaka Y; Kataoka F; Sasaki A; Masamune A
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATDC induces an invasive switch in KRAS-induced pancreatic tumorigenesis.
    Wang L; Yang H; Abel EV; Ney GM; Palmbos PL; Bednar F; Zhang Y; Leflein J; Waghray M; Owens S; Wilkinson JE; Prasad J; Ljungman M; Rhim AD; Pasca di Magliano M; Simeone DM
    Genes Dev; 2015 Jan; 29(2):171-83. PubMed ID: 25593307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Senescence program and its reprogramming in pancreatic premalignancy.
    Yang K; Li X; Xie K
    Cell Death Dis; 2023 Aug; 14(8):528. PubMed ID: 37591827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FXYD3 is overexpressed in pancreatic ductal adenocarcinoma and influences pancreatic cancer cell growth.
    Kayed H; Kleeff J; Kolb A; Ketterer K; Keleg S; Felix K; Giese T; Penzel R; Zentgraf H; Büchler MW; Korc M; Friess H
    Int J Cancer; 2006 Jan; 118(1):43-54. PubMed ID: 16003754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncoupling the Senescence-Associated Secretory Phenotype from Cell Cycle Exit via Interleukin-1 Inactivation Unveils Its Protumorigenic Role.
    Lau L; Porciuncula A; Yu A; Iwakura Y; David G
    Mol Cell Biol; 2019 Jun; 39(12):. PubMed ID: 30988157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SASP: Tumor Suppressor or Promoter? Yes!
    Rao SG; Jackson JG
    Trends Cancer; 2016 Nov; 2(11):676-687. PubMed ID: 28741506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mounting Pressure in the Microenvironment: Fluids, Solids, and Cells in Pancreatic Ductal Adenocarcinoma.
    DuFort CC; DelGiorno KE; Hingorani SR
    Gastroenterology; 2016 Jun; 150(7):1545-1557.e2. PubMed ID: 27072672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic, Molecular, and Translational Applications in Pancreatic Ductal Adenocarcinoma: Current Evidence and Future Concepts.
    Malla RR; Kumari S
    Crit Rev Oncog; 2019; 24(2):119-132. PubMed ID: 31679207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Senescence and cancer: An evolving inflammatory paradox.
    Ruhland MK; Coussens LM; Stewart SA
    Biochim Biophys Acta; 2016 Jan; 1865(1):14-22. PubMed ID: 26453912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteasome-dependent senescent tumor cells mediate immunosuppression through CCL20 secretion and M2 polarization in pancreatic ductal adenocarcinoma.
    Wu M; Han J; Wu H; Liu Z
    Front Immunol; 2023; 14():1216376. PubMed ID: 37398643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Senolytic elimination of Cox2-expressing senescent cells inhibits the growth of premalignant pancreatic lesions.
    Kolodkin-Gal D; Roitman L; Ovadya Y; Azazmeh N; Assouline B; Schlesinger Y; Kalifa R; Horwitz S; Khalatnik Y; Hochner-Ger A; Imam A; Demma JA; Winter E; Benyamini H; Elgavish S; Khatib AA; Meir K; Atlan K; Pikarsky E; Parnas O; Dor Y; Zamir G; Ben-Porath I; Krizhanovsky V
    Gut; 2022 Feb; 71(2):345-355. PubMed ID: 33649045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterotypic paracrine signaling drives fibroblast senescence and tumor progression of large cell carcinoma of the lung.
    Lugo R; Gabasa M; Andriani F; Puig M; Facchinetti F; Ramírez J; Gómez-Caro A; Pastorino U; Fuster G; Almendros I; Gascón P; Davalos A; Reguart N; Roz L; Alcaraz J
    Oncotarget; 2016 Dec; 7(50):82324-82337. PubMed ID: 27384989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.